Novo Nordisk removes CEO due to pressure from Eli Lilly
On Friday, Novo Nordisk, the maker of Ozempic and Wegovy, dismissed its CEO, Lars Fruergaard Jorgensen, marking the end of a significant leadership chapter as it navigates a tough climate in the competitive obesity drug sector. This move came shortly after the Danish pharmaceutical giant adjusted its sales and profit projections downward for the first […]
Wegovy producer Novo Nordisk lowers profit expectations as US prescriptions decline.
Novo Nordisk in Denmark has cut its annual revenue and profit projections due to a slowdown in Wegovy sales, a weight loss medication, as prescriptions in the US have declined. The success of Wegovy, along with booming sales of diabetes drugs, elevated these companies to the status of Europe’s most valuable publicly traded firms, reaching […]
Hims & Hers to offer Wegovy thanks to new partnership with Novo Nordisk
Please see what you are clicking on foxbusiness.com. Hims & Hers Health announced on Tuesday that it will bundle Telehealth Platform membership and Wegovy through a new collaboration with drug maker Novo Nordisk. The bundle offers all doses combined with Novo Nordisk's popular weight loss medication with HIMS & HERS membership, providing “24/7 care, ongoing […]
Novo Nordisk shares fall on weight loss drug trial
Custom Care Medical Internal Medicine Dr. Frank Contessa will be taking part in “Varney & Co.” to consider the White House's latest proposals on Medicaid and Medicare to cover obesity medications. Novo Nordisk's shares slipped down in trading Monday morning after the company announced the results of its latest weight loss pill trial. Results from […]
Novo Nordisk to sell Wegovy for $499 a month to cash-paying US customers
Novo Nordisk said Wednesday it will begin selling its weight loss drug Wegovy at a discounted $499 per month to cash-paying patients as it is working towards a transition to competitive dynamics in the US obesity drug market. The move comes more than a week after rival Eli Lily cuts the price of weight loss […]
Novo Nordisk slashes Wegovy prices through direct-to-consumer pharmacy
Drug manufacturer Novo Nordisk announced Wednesday that it will offer a program directly from patients so that uninsured and uninsured individuals can pay cash at significantly reduced costs for weight-reduced products. The drugmaker has appointed a new program, Novocare® Pharmacy. It sells all dose strengths from Wegovy for $499 per month. Most patients pay a […]
Stocks making the biggest moves midday: Novo Nordisk, J.B. Hunt, Qorvo and more – CNBC
Check out the companies that are trending in intraday trading. Cryptocurrency Stocks – Stocks related to cryptocurrencies soared following reports that President-elect Donald Trump may issue an executive order making cryptocurrencies a national priority as early as the first day of his new term. Shares of cryptocurrency exchange operators Coinbase and Robinhood rose 4.9% and […]
Novo Nordisk shares plummet after successor to Wegovy disappoints in study
Novo Nordisk announced on Friday disappointing results from a late-stage trial of its experimental next-generation obesity drug Kaglisema, wiping its market value by $125 billion. The drug candidate's lower-than-expected weight loss is a blow to the Danish company's ambitions to replace its weight-loss drug Wegoby, which is more powerful than Eli Lilly's rival Zepbound (also […]
Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats
Novo Nordisk has asked the Food and Drug Administration (FDA) to block compounding pharmacies from selling proprietary versions of its popular weight loss drug Wigoby and diabetes drug Ozempic, saying the drugs are too complex for pharmacies to manufacture safely. We are asking them to stop their production. Compounded anti-obesity drugs are sold at significantly […]
Bernie Sanders Demands Novo Nordisk CEO Lower Weight Loss Drug Prices For Americans
Sen. Bernie Sanders (I-VT) speaks during a press conference on prescription drug costs in the United States at the Dirksen Senator's Office Building in Washington, DC, September 17, 2024. (Photo by Kevin Deitch/Getty Images) OAN Staff Avril ElfiTuesday, September 24, 2024 3:42 PM At a Senate committee hearing on Tuesday, lawmakers questioned makers of popular […]